StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report released on Saturday. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens lifted their target price on shares of Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a research note on Friday, January 31st.
Get Our Latest Analysis on Veradigm
Veradigm Stock Performance
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- How to Invest in Insurance Companies: A Guide
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- What is the FTSE 100 index?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- ESG Stocks, What Investors Should Know
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
